Invega Approved as Treatment for Schizophrenia in Adolescents

Links shared publicly online about this topic.

  • 372
    total visits

Invega Approved as Treatment for Schizophrenia in Adolescents

drugs.com

Invega (paliperidone) is used to treat schizophrenia and schizoaffective disorder. Includes Invega side effects, interactions and indications.

View full resource at drugs.com

Tags: Bipolar Disorder, Depression, Schizophrenia, Schizoaffective Disorder, Psychotic Disorder, Disease and Condition, Drug

  • Share

Most Recently Shared on April 12, 2011 at 12:14 am By:

Drugs_Devices Drugs and Devices OW

Invega Approved as Treatment for Schizophrenia in Adolescents: TITUSVILLE, N.J., April 11, 2011 /PRNewswir... http://bit.ly/e10uNI #drug

1 year ago...

Invega Approved as Treatment for Schizophrenia in Teens | Psych Central News

psychcentral.com — “A new drug has been approved for a rare population --teens with schizophrenia. The illness is typically diagnosed first in young adulthood, usually the earlyView full resource at psychcentral.com

  • View Related
  • Share

Most Recently Shared on April 13, 2011 at 6:41 pm By:

psychcentral Psych Central Health Site

News: Invega Approved as Treatment for Schizophrenia in Teens http://bit.ly/dMYdtG

1 year ago...

INVEGA(R) Approved As Treatment For Schizophrenia In Adolescents

medicalnewstoday.com — “The U.S. Food and Drug Administration (FDA) on April 6 approved INVEGA® (paliperidone) extended-release tablets for the treatment of schizophrenia in adolescents 12 to 17 years of age. The efView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 12, 2011 at 10:05 am By:

mnt_schizophren MNT Schizophrenia Health News

INVEGA(R) Approved As Treatment For Schizophrenia In Adolescents http://mnt.to/3TvT #schizophrenia

1 year ago...

Invega Gains Indication for Schizophrenia in Adolescents - ONA

oncologynurseadvisor.com — “The FDA has approved Invega (paliperidone extended-release tablets; Janssen) for the treatment of schizophrenia in adolescents 12--17 years of age.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on April 11, 2011 at 2:52 pm By:

Invega Gains Indication for Schizophrenia in Adolescents - MPR

empr.com — “The FDA has approved Invega (paliperidone extended-release tablets; Janssen) for the treatment of schizophrenia in adolescents 12--17 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on April 11, 2011 at 2:51 pm By:

eMPR MPR Medical Publisher

MPR News: Invega Gains Indication for Schizophrenia in Adolescents: The FDA has approved Invega (paliperidone ex... http://bit.ly/gIMbNx

1 year ago...

INVEGA® Approved as Treatment for Schizophrenia in Adolescents - Press Release - Digital Journal

digitaljournal.com — “Digital Journal is a digital media news network with thousands of Digital Journalists in 200 countries around the world. Join us!View full resource at digitaljournal.com

  • View Related
  • Share

Most Recently Shared on April 11, 2011 at 12:18 pm By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

INVEGA® Approved as Treatment for Schizophrenia in Adolescents http://bit.ly/f9DCQB #psychosis #schizo

1 year ago...

Psychiatry Article | Olanzapine

mdlinx.com — “Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patientsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 2, 2010 at 8:50 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipola... http://bit.ly/h2uM2i #PSY

1 year ago...

FDA Approves Lilly's Zyprexa For Two Adolescent Indications

medicalnewstoday.com — “The U.S. Food and Drug Administration (FDA) approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar IView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 5, 2009 at 12:19 pm By:

mnt_bipolar MNT Bipolar News Health News

FDA Approves Lilly's Zyprexa For Two Adolescent Indications: The U.S. Food and Drug Administration (FDA) approv.. http://bit.ly/57Yb0c

2 years ago...

FDA Approves INVEGA(R) SUSTENNA(TM) For The Acute And Maintenance Treatment Of Schizophrenia

medicalnewstoday.com — “The U.S. Food and Drug Administration approved INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 4, 2009 at 10:36 am By:

psychiatry_md psychiatryrounds Psychiatry and Support

FDA Approves INVEGA(R) SUSTENNA(TM) For The Acute And Maintenance Treatment Of Schizophrenia: The U.S. Food and .. http://bit.ly/28t8Q

3 years ago...

FDA Approves Invega Sustenna for the Acute and Maintenance Treatment of Schizophrenia

drugs.com — “Invega Sustenna (paliperidone palmitate) is used to treat schizophrenia. Includes Invega Sustenna side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 3, 2009 at 11:57 pm By:

drugscom Drugs.com Health Site

FDA Approves Invega Sustenna for the Acute and Maintenance Treatment of Schizophrenia - http://bit.ly/JkPxL

3 years ago...

Invega Sustenna approved for treatment of schizophrenia - MPR

empr.com — “The FDA has approved Invega Sustenna (paliperidone palmitate, from Janssen) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adults.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 3, 2009 at 4:13 pm By:

eMPR MPR Medical Publisher

MPR News: Invega Sustenna approved for treatment of schizophrenia: The FDA has approved Invega Sustenna.. http://bit.ly/15P18V

3 years ago...

FDA approves Invega Sustenna for schizophrenia

news-medical.net — “The U.S. Food and Drug Administration today approved Invega Sustenna (paliperidone palmitate) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adults.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 3, 2009 at 2:55 am By:

WRY999 William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor

New long-acting injectable medication approved by the FDA for schizophrenia. #invega http://bit.ly/4pSZiY

3 years ago...

Advertisement